Research at Oslo University Hospital

 

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

 

Latest news

Guest seminar, Sept 19th - Darren Saunders

“Linking genotype to phenotype in cancer: proteostasis and metabolic reprogramming"

 
Darren Saunders from the Ubiquitin Signaling Group, Garvan Institute, Sydney, Australia, will give a lecture entitled “Linking genotype to phenotype in cancer: proteostasis and metabolic reprogramming".
Time: Friday, September 19th, 12:00
Place: Seminar Room 2, Institute for Cancer Research
 
 

Official opening of the KG Jebsen Colorectal Cancer Research Centre

 
Hans Peter Jebsen and Ragnhild A. Lothe
Hans Peter Jebsen and Ragnhild A. Lothe

The K.G. Jebsen Colorectal Cancer Research Centre was recently officially opened by the chair of the Jebsen Foundation’s board of directors, Hans Peter Jebsen. Prof. Ragnhild A. Lothe will lead the Centre together with the interdisciplinary PI team consisting of Prof. Michael Bretthauer (gastroenterologist), Prof. Arild Nesbakken (surgeon), Prof. Kjell Tveit (oncologist) and ass. Prof. Rolf I. Skotheim (bioinformatician).

This is the only Jebsen Centre in Oslo that has Oslo University Hospital as its main host institution. Prof. Sigbjørn Smeland, head of the hosting Division of Cancer, Surgery and Transplantation, said in his talk that the Centre was an excellent example of how to organise and succeed in translational research within a Comprehensive Cancer Centre.

 
 

Two researchers from Oslo University Hospital among the world's most influential

 
Blomhoff (left) and Kjeldsen
Blomhoff (left) and Kjeldsen

Thomson Reuters - the multinational media and information firm that operates in more than 100 countries, and has more than 60,000 employees around the world - has selected The "World's most influential scientific minds 2014".
They have listed some 3,200 researchers who published the greatest number of highly cited papers in one of 21 broad fields. These highly cited researchers were determined by analyzing at citation data over the last 11 years to identify those who published the highest-impact work (2002—2012 and 2012—2013). These individuals are influencing the future direction of their fields, and of the world.
Seven Norwegian scientists are on the list, and of these two researchers represent Oslo University Hospital. These are Rune Blomhoff from the Department of Clinical Service at the Divsion of Cancer, Surgery and Transplantation and Sverre Kjeldsen from the Department of Cardiology, at the Medical Clinic.

 
 

Oslo University Hospital awarding excellent research

 
From left: Leithe, Sollid and Emblem (photo Ram Gupta)
From left: Leithe, Sollid and Emblem (photo Ram Gupta)

Three scientists recently received awards for their outstandig work at a ceremony taking place at Oslo University Hospital. This is the second year such prizes have been distributed in order to honour excellent scientific work.
The major prize - the "Excellent Researcher Award" - went to professor Ludvig M. Sollid. Edvard Leithe and Kyrre Eeg Emblem both received the "Early Career Award".
The prize money - 300.000 and 150.000 NOK respectively - is earmarked for research activities.

 
 

OUH researchers first and last authors on New England Journal of Medicine article

 
Løberg (left) and Bretthauer
Løberg (left) and Bretthauer

Magnus Løberg and Michael Bretthauer from the Department of Transplantation Medicine at Oslo University Hospital are first and last author respectively on an article recently published in New Eng J Med (journal impact factor 54.42), entitled "Long-Term Colorectal-Cancer Mortality after Adenoma Removal".
Taking advantage of nationwide data in the Cancer Registry of Norway on patients who have had colorectal adenomas removed, they have evaluated colorectal-cancer mortality in a large, population-based cohort with virtually complete follow-up for death from colorectal cancer.
The findings are commented in an editorial in NEJM.

 
 

UiO's Innovations Prize 2014 to Øyvind S. Bruland

 
Øyvind S. Bruland (photo Ola Sæther)
Øyvind S. Bruland (photo Ola Sæther)

Professor Øyvind S. Bruland, head of the Sarcoma group at the from the Department of Oncology at Oslo University Hospital, has together with Roy Hartwig Larsen won the University of Oslo Innovation Prize for 2014.

Bruland and his research has in this connection been thoroughly presented in UiO's web newspaper "Uniforum" and in UiO's research magazine "Apollon" (download in pdf format).